International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-5 doi: https://doi.org/10.5281/zenodo.13991350
Original Research Article
Diagnostic Accuracy of CT Scan Versus MRI in Detecting Brain Tumors
Published
Oct. 25, 2024
Abstract

Background: Early detection of brain tumors is fundamental to improve treatment outcomes and patient survival. Although computed tomography is commonly used because it is accessible, magnetic resonance imaging has become more popular because of its higher image resolution. This study aimed to compare the diagnostic accuracy of computed tomography and magnetic resonance imaging in detecting brain tumors. Methods: The study included 120 participants between the ages of 20 to 75 (mean age: 48), each of whom had a computed tomography and magnetic resonance imaging scan for suspected brain tumors. Diagnostic measures such as true positives (TP), true negatives (TN), false positives (FP) and false negatives (FN) were calculated. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and accuracy for each model. Results: CT scans identified 45 TP, 60 TN, 10 FP, and 5 FN cases. The sensitivity of CT scans was 90.0%, specificity was 85.7%, PPV was 81.8%, NPV was 92.3%, and accuracy was 87.5%. MRI identified 48 TP, 65 TN, 6 FP, and 1 FN case. The sensitivity of MRI was 98.0%, specificity was 91.5%, PPV was 88.9%, NPV was 98.5%, and accuracy was 93.8%. MRI demonstrated higher sensitivity, specificity, PPV, NPV, and accuracy compared to CT scans.Conclusion: Magnetic resonance imaging is superior to computed tomography in detecting brain tumors. It has greater overall sensitivity and accuracy. These findings suggest that MRI should be used to diagnose brain tumors. Especially where high sensitivity is important. However, factors such as cost and accessibility should be considered when choosing between these methods

Recommended Articles
Loading Image...
Volume-5, Issue-5
Citations
135 Views
252 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved